Citation Impact

Citing Papers

Antidote-mediated control of an anticoagulant aptamer in vivo
2004
A placebo‐controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure
2001
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults
2004
Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia
2004
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Delavirdine
2000
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Bivalirudin: a review
2005
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
2011
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Growth hormone deficiency and vascular risk
2002
Aptamers as therapeutics
2010 Standout
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro
2007
Sex-Based Analysis of Outcome in Patients With Acute Myocardial Infarction Treated Predominantly With Percutaneous Coronary Intervention
2002
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery
2001
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Biomedical Importance of Indoles
2013 Standout
Explaining the Phenomenon of Nitrate Tolerance
2005
In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA
2005
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.
2000

Works of Dawn Bell being referenced

Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370
2000
Effects of Intermittent Transdermal Nitroglycerin on Occurrence of Ischemia After Patch Removal: Results of the Second Transdermal Intermittent Dosing Evaluation Study (TIDES-II) fn1fn1This study was supported by a grant from Ciba-Geigy Pharmaceuticals, Summit, New Jersey.
1997
Analysis of Number Needed to Treat and Cost of Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Interventions and Acute Coronary Syndromes
1999
Safety, Tolerability, and Pharmacokinetic Effects of Thalidomide in Patients Infected with Human Immunodeficiency Virus: AIDS Clinical Trials Group 267
2002
Clinical Pharmacology of Bivalirudin
2002
Rash in Patients Receiving Ticlopidine after Intracoronary Stent Placement
1999
Myocardial Infarction in Women: A Critical Appraisal of Gender Differences in Outcomes
2000
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial
1999
Endothelial Dysfunction: Implications for Therapy of Cardiovascular Diseases
1998
Rankless by CCL
2026